Page last updated: 2024-09-04

1-methyl-4-phenyl-2,3-dihydropyridinium and Parkinson Disease

1-methyl-4-phenyl-2,3-dihydropyridinium has been researched along with Parkinson Disease in 3 studies

*Parkinson Disease: A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75) [MeSH]

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brunner, T; Cirri, E; Ferger, B; Friemel, A; Hiller, K; Karreman, C; Leist, M; Marx, A; Meiser, J; Möller, HM; Odermatt, M; Pape, R; Pasquarelli, N; Ringwald, M; Schildknecht, S; Strittmatter, T1
Coates, PW; Everse, J1
Beckley, DJ; Bloem, BR; Remler, MP; Roos, RA; van Dijk, JG; Zwinderman, AH1

Other Studies

3 other study(ies) available for 1-methyl-4-phenyl-2,3-dihydropyridinium and Parkinson Disease

ArticleYear
Preferential Extracellular Generation of the Active Parkinsonian Toxin MPP+ by Transporter-Independent Export of the Intermediate MPDP+.
    Antioxidants & redox signaling, 2015, Nov-01, Volume: 23, Issue:13

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Astrocytes; Biological Transport; Catecholamines; Cell Line; Cell Membrane; Diffusion; Dopaminergic Neurons; Extracellular Fluid; Humans; Monoamine Oxidase; Oxidation-Reduction; Parkinson Disease; Pyridinium Compounds

2015
The cytotoxic activity of lactoperoxidase: enhancement and inhibition by neuroactive compounds.
    Free radical biology & medicine, 2004, Sep-15, Volume: 37, Issue:6

    Topics: 1-Methyl-4-phenylpyridinium; Animals; Apomorphine; Aspirin; Brain; Catalysis; Cell Line, Tumor; Dogs; Dopamine; Erythrocytes; Free Radicals; Herbicides; Humans; Lactoperoxidase; Neurons; Parkinson Disease; Peroxidase; Pyridinium Compounds; Spectrophotometry; Time Factors; Uric Acid

2004
Influence of dopaminergic medication on automatic postural responses and balance impairment in Parkinson's disease.
    Movement disorders : official journal of the Movement Disorder Society, 1996, Volume: 11, Issue:5

    Topics: Adult; Aged; Dopamine Agents; Female; Humans; Male; Middle Aged; Motor Skills; Parkinson Disease; Postural Balance; Posture; Pyridinium Compounds

1996